Pharmacogenomics journal provides a forum for publishing new findings on Pharmacogenomics. The primary research objective of the pharmacogenomics journal is to encourage and assist the development of better and faster measures of Pharmacogenomics activities. In cases where we believe we can contribute directly, as opposed to through highlighting the work of others, we are producing our own measures of Pharmacogenomics research. Our work is mainly of interest to investors, organizations and individuals in the financial sector and to significant corporations with global operations, as well as governments and academic researchers.
Last date updated on June, 2021